Cigna Increases FY22 Guidance After Street Beating Q2 Earnings

  • Cigna Corp CI reports Q2 revenues of $45.5 billion, +5.45% Y/Y, ahead of the consensus of $44.41 billion.
  • Adjusted income from operations increased 9.6% to $1.98 billion with strong contributions from Evernorth and Cigna Healthcare.
  • Q2 adjusted EPS reached $6.22 compared with $5.24 a year ago, beating the consensus of $5.48. 
  • By the end of 2021, Cigna boasted 108.2 million pharmacy benefit customers, +6.2% Y/Y. Medical membership reached 17.81 million, up from 16.92 million a year ago.
  • At its Evernorth subsidiary, revenues were up 7% Y/Y reaching $34.86 billion, reflecting organic growth in specialty pharmacy services.
  • Revenues were up 4% at its health plan, reaching $11.34 billion. 
  • Guidance: For FY22, Cigna expects EPS of at least $22.90 (consensus of $22.72), up from prior guidance of at least $22.60.
  • It projects FY22 revenues of at least $178 billion (at least $177 billion expected earlier)
  • For FY22, the company expects total Medical Customer Growth (lives) of at least 800,000, up from the 725,000 anticipated earlier.
  • Price Action: CI shares are up 4.33% at $283.50 during the premarket session on the last check Thursday.
  • Photo via Wikimedia Commons
Loading...
Loading...
CI Logo
CIThe Cigna Group
$314.400.60%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
60.73
Growth
82.03
Quality
55.62
Value
41.72
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...